Sanofi can give it the boot if they were not interested.
Sanofi is a big deal - to interest them it would have to be worth their time and trouble.
The Oromist thing seems to work - with the right medication - a fraction of the time to work compared to pills and it needs a fraction of the Medication - that seems like a winner if they plug in the right medicine.
Why would Sanofi bother with a piss ant outfit unless it was in their interest to supercharge something in their pipeline?
Its in further development
The agreement is for SUDAto carry out a fully-funded feasibility study that will terminate on March 30th,2021.
As a feasibility study, this study is not intended to generate significant revenue.
Based on the outcomes of this feasibility study,SANOFI and SUDA may enter into further collaboration.
Arovella ALA-023 (Not disclosed) is in preclinical:
Preclinical studies involve the initial stages of looking for new cures and potential treatments for both new and well-established diseases. It is the first stage of the Drug Discovery process.
ADME, absorption, distribution, metabolism, and excretion; API, active pharmaceutical ingredient; PK, pharmacokinetics; Prep, preparation; Tox, toxicity.
Once a lead compound is found, preclinical phase of drug development begins with in vivo research to determine the efficacy and safety of the drug. Researchers determine the following about the drug: Absorption, distribution, metabolization, and excretion information. Potential benefits and mechanisms of action.
- Forums
- ASX - By Stock
- Ann: Board Changes
Sanofi can give it the boot if they were not interested. Sanofi...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALA (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $205.1M |
Open | High | Low | Value | Volume |
19.0¢ | 20.5¢ | 18.8¢ | $291.0K | 1.504M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 157723 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 33780 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 157723 | 0.190 |
6 | 189048 | 0.185 |
9 | 870795 | 0.180 |
5 | 138708 | 0.175 |
5 | 224410 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 33780 | 2 |
0.200 | 430780 | 9 |
0.205 | 354381 | 8 |
0.210 | 243395 | 4 |
0.215 | 210000 | 3 |
Last trade - 14.55pm 17/10/2024 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online